21 - 129 - GRAFT-VS-HOST DISEASE Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

most important risk factor for chronic GVHD

A

history of acute GVHD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The most common presentation of acute GVHD begins with

A

erythematous-dusky macules and papules of the volar and plantar surfaces and ears that may rapidly become a diffuse morbilliform exanthem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
A
19
Q
A
20
Q

These are diagnostic clinical features of chronic GVHD except?

a. poikiloderma
b. lichen planus-like eruption
c. lichen striatus-like eruption
d. morphea-like features
e. none of the above

A

c. lichen striatus-like eruption

21
Q

hese are major risk factors for the development of GVHD except?

a. Female recipient/male donor
b. Unrelated donor
c. Donor leukocyte infusion
d. Stem cell source

A

A (female donor/male recipient)

22
Q

These are distinctive clinical features of chronic GVHD except?

a. Depigmentation
b. Papulosquamous lesions
c. Pterygium
d. Scaling
e. None of the above

A

E

23
Q

Which statement correctly describes the histopathology of acute GVHD?

a. sparse lymphocytic infiltrates
b. sclerosis of upper dermis
c. atrophy of epidermis
d. follicular plugging

A

A

24
Q

Which stage of GVHD is characterized clinically by lesions in >50% BSA, subepidermal clefting histologically, with bilirubin levels of 6 to 14.9 mg/dL?

A. Stage 1

B. Stage 2

C. Stage 3

D. Stage 4

A

C

25
Q

Risk factors for chronic GVHD

A
  • history of acute GVHD - most important RF
  • human leukocyte antigen incompatibility,
  • older age,
  • female DONOR/male RECIPIENT,
  • peripheral blood stem cell source (vs bone marrow)
26
Q

first line in the treatment of moderate to severe chronic GVHD

A

Systemic steroids

27
Q

in this type of transplantation, the patient’s own Hematopoietic stem cell are returned to the patient following preparative chemotherapy with or without radiation

A

autologous transplantation

28
Q

transfer of hematopoietic stem cell (HCs) from a related (nonidentical) or unrelated donor to a recipient

A

Allogeneic HCT (allo-HCT)

29
Q

transfer of HCs between identical twins

A

Syngeneic transplantation

30
Q

primary cause of non–relapse-related morbidity and mortality in alloHCT, and also rarely occurs following transplantation of solid organs, transfusion of blood products, and autologous transplantation

A

Graftversus-host disease (GVHD)

31
Q

the single most important predictor of GVHD

A

degree of human leukocyte antigen (HLA) mismatch between donor and recipient

32
Q

organs most commonly associated with acute GVHD

A
  1. Skin - 81%
  2. GI - 54%
  3. Liver - 50%

Skin involvement is often the first indicator of acute GVHD (81%), followed by GI (54%) and liver disease (50%)

33
Q

What are the 3 proposed basic requirements for GVHD according to Billingham?

A

(a) immunocompetent transplanted cells,

(b) host antigens recognizable by the transplanted cells and lacking in the donor, and

(c) a host incapable of mounting an immune response to the transplanted cells

34
Q

The use of particular chemotherapeutic agents such as ____________ may render the differential diagnosis of toxic erythema of chemotherapy more likely.

A

Cytarabine

35
Q

predisposition to these areas may help distinguish new onset acute GVHD from other morbilliform eruptions,

A

predisposition for acral and perifollicular sites

although these features are not always present.

36
Q

What are the diagnostic clinical features of Chronic GVHD

A

■ Poikiloderma

■ Lichen sclerosus–like lesions

■ Lichen planus–like eruption

■ Morphea-like lesions

■ Sclerotic features

37
Q

What clinical features are seen in both acute and chronic GVHD

A

■ Erythema

■ Maculopapular rash

■ Pruritus

38
Q

commonly affected organs in acute GVHD

A

skin, GI tract, liver

typically presenting with skin rash, new-onset elevation of total bilirubin, and/or voluminous diarrhea

39
Q

most frequently affected sites in chronic GVHD

A

skin and nails, oral mucosa, eyes, liver, lungs, and marrow (usually thrombocytopenia)

40
Q

econd only to skin involvement in frequency in chronic GVHD

A

Mucosal disease

Erythema, lichen planus–like changes with Wickham striae, erosions and ulcerations, and mucoceles are the most common manifestations

41
Q

most commonly affected mucosa in chronic GVHD

A

buccal mucosa

followed by the lips, tongue, and soft palate

42
Q

histopathologic hallmark feature of acute GVHD

A

presence of necrotic keratinocytes accompanied by a dermal lymphocytic infiltrate (usually sparse) and basal vacuolar interface alteration

43
Q
A